# Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear

> **NCT04470167** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tego Science, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Rotator Cuff Injuries

## Interventions

- **BIOLOGICAL:** TPX-115
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04470167
- **Lead sponsor:** Tego Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-26
- **Primary completion:** 2022-02-17
- **Final completion:** 2022-02-17
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04470167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04470167, "Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04470167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*